We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 147.32 | 174.45 | 223.43 | 236.34 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 201.51 | 254.00 | 316.72 | 351.23 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44,000 | 52,000 | 56,000 | 72,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19 | 0.19 | 0.21 | 0.19 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,550.60 | 10,072.00 | 11,555.00 | 13,942.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.60% | 43.60% | 43.56% | 43.75% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,327.00 | 1,185.00 | 1,875.00 | 1,871.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.52% | 11.77% | 16.23% | 13.42% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,116.00 | 966.00 | 1,471.00 | 1,503.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 599.60 | 697.00 | 843.00 | 1,122.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.66 | 46.87 | 52.40 | 54.44 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.30 | 4.51 | 6.67 | 5.83 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.61 | 9.46 | 11.71 | 7.54 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.87) | (0.90) | (0.64) | (0.57) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.74 | 8.55 | 11.07 | 6.97 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.70 | 50.33 | 91.52 | 91.16 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 210.30 | 214.90 | 220.50 | 256.10 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.47 | 49.89 | 43.40 | 44.31 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.61 | 4.80 | 5.42 | 4.75 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.29 | 4.47 | 3.10 | 2.84 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.23 | 5.47 | 5.28 | 5.57 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.07 | 29.97 | 25.01 | 43.52 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,390.00 | 2,032.00 | 2,583.00 | 1,930.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (182.70) | (194.00) | (142.00) | (145.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,207.30 | 1,838.00 | 2,441.00 | 1,785.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 946.60 | 1,051.40 | 14,853.00 | 1,837.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,114.80 | 7,006.00 | 12,732.00 | 12,104.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,376.40 | 6,034.50 | (2,255.00) | 10,708.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,190.20 | 10,815.30 | 20,180.00 | 23,347.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.11% | 2.16% | 2.53% | 2.21% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.80% | 5.50% | 7.87% | 4.61% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.55% | 9.70% | 9.44% | 6.86% | — | — | — |
ROE
|
Arthur J. Gallagher & Co. (AJG) Latest News
22 Sep
Silver Beech Capital's Q2 2026 investor letter highlights Arthur J. Gallagher & Co. (AJG) as a top holding. AJG, the world’s third-largest insurance broker, has grown earnings per share by more than 17% per year over the last decade on a disciplined acquisition program and a supportive pricing environment. The letter notes a sharp share-price decline—roughly 45% from a June 2025 high to a May 2026 low—and a steep multiple compression, from about 30x forward earnings to around 14x, prompting management to describe equity as woefully undervalued and accelerate its stock repurchase. Silver Beech disclosed buying AJG in the first half of 2026. As of Sept. 21, 2026, AJG traded at $236.61 with a market cap near $60.6B; the piece also cites a ~55-hedge-fund stake landscape and a Citi upgrade seeing a return opportunity in insurance brokers. The AI-capex backdrop provides broader market context. Undervalued, driven by earnings growth and an accelerated buyback, could moderately lift sentiment and valuation.
19 Sep
Arthur J. Gallagher & Co. completed a Colorado acquisition as part of ongoing strategic buildup. Colorado deal adds incremental scale to existing operations but signals no fundamental shift.
18 Sep
Arthur J. Gallagher & Co. acquires McMillan Insurance, expanding its brokerage operations. Acquisition supports Arthur J. Gallagher & Co. brokerage growth without altering core trajectory.
7 Sep
AJG risk management segment posts higher organic growth than brokerage operations. Faster risk management growth supports diversified revenue and modestly lifts overall performance outlook.
3 Sep
PFG acquires Beam Benefits to accelerate specialty benefits growth. Acquisition of Beam Benefits represents major strategic move accelerating specialty benefits growth.
Arthur J. Gallagher & Co. (AJG) faces questions over its ability to sustain mid-teens EPS growth for multiple years ahead. Speculation on sustained EPS growth can shape investor expectations for AJG's earnings trajectory.
25 Aug
Arthur J. Gallagher & Co. stock rose 9.7% on surging revenue and earnings growth. Surging revenue and earnings growth signals stronger financial performance with potential to lift market valuation.
24 Aug
Arthur J. Gallagher & Co. exhibits resilient organic growth that underpins its long-term expansion strategy. Resilient organic growth directly bolsters AJG expansion prospects and market trajectory.
Strong growth lifted Arthur J. Gallagher & Co. stock, raising questions whether shares represent a bargain at current levels. Strong growth boosted Arthur J. Gallagher & Co. shares and shaped market views on valuation.
12 Aug
Rising healthcare costs are pushing employers to exert greater oversight over benefits, boosting demand for Arthur J. Gallagher & Co.'s services in benefits management. Healthcare cost pressures create expanded market for Gallagher's employer benefits solutions.
5 Aug
Arthur J. Gallagher & Co. acquires Apollo Insurance Solutions Ltd. Acquisition represents major strategic expansion in insurance solutions.
Arthur J. Gallagher & Co. acquires Apollo Insurance Solutions Ltd. Acquisition expands Arthur J. Gallagher & Co. insurance solutions reach and operations.
1 Aug
AJG posted Q2 organic growth supported by M&A integration that offset pricing headwinds. Q2 organic growth and M&A integration indicate moderate effects on AJG financial performance and positioning.
31 Jul
Arthur J. Gallagher & Co. posted record revenue growth in Q2 2026 earnings call highlights. Record revenue growth signals stronger financial results and improved market position for AJG.
Arthur J. Gallagher & Co. held its Q2 earnings call, highlighting key financial metrics, operational updates and future outlook for the insurance brokerage firm. Q2 earnings updates deliver financial results and guidance that moderately affect near-term stock valuation and investor views.
AJG reported Q2 revenue growth that positions the stock as potentially 9% undervalued. Q2 revenue growth signals moderate influence on AJG financial performance and valuation.
30 Jul
Arthur J. Gallagher & Co. held its Q2 2026 earnings call to report quarterly financial results and business updates. Quarterly earnings disclosures can moderately influence near-term stock price and investor sentiment.
Arthur J. Gallagher & Co. released its second quarter 2026 financial results. Quarterly earnings results shape near-term market views on company performance.
21 Jul
Arthur J. Gallagher & Co. acquires W.N. Tuscano Agency, Inc. Acquisition expands Arthur J. Gallagher & Co. agency network and market reach.
15 Jul
Piper Sandler revamps insurance coverage, upgrading Arthur J. Gallagher & Co. (AJG) while cutting ratings on five other firms. Piper Sandler upgrade signals positive outlook for AJG that may lift near-term stock valuation and sentiment.
14 Jul
Arthur J. Gallagher & Co. acquires Med James to expand specialty insurance operations. Acquisition adds specialty insurance capabilities and supports AJG growth.
13 Jul
Arthur J. Gallagher & Co. acquires Med James to strengthen its specialty insurance operations. Med James acquisition expands Arthur J. Gallagher & Co. specialty insurance portfolio and reach.
9 Jul
Arthur J. Gallagher & Co. acquires Med James, Inc. Acquisition moderately expands AJG operations and competitive positioning without fundamentally altering company trajectory.
8 Jul
Arthur J. Gallagher & Co. acquires WMB to expand its commercial insurance operations in Canada. WMB acquisition strengthens AJG Canada presence as incremental growth step.
7 Jul
Arthur J. Gallagher & Co. acquires Wilson M. Beck Insurance Services Inc. Acquisition expands Arthur J. Gallagher & Co. insurance services footprint and operations.
3 Jul
Arthur J. Gallagher & Co. shows multiple indicators of exceeding upcoming earnings estimates, supported by continued growth in core brokerage and risk management operations amid favorable market conditions. Expected earnings beat can lift near-term stock price and sentiment but does not signal major strategic or structural change.
24 Jun
AJG acquires a Cincinnati firm to expand its employee benefits segment. Acquisition adds modestly to employee benefits operations and competitive position.
Aon enters final year of 3x3 Plan with questions on strategy delivery and results amid insurance brokerage competition including Arthur J. Gallagher & Co. Aon's 3x3 Plan conclusion may shift market shares and competitive positioning for AJG without transforming its core trajectory.
10 Jun
Arthur J. Gallagher (AJG) posts strong earnings and acquisition-led growth, triggering a valuation reassessment. Earnings strength combined with acquisition-driven growth positions AJG for materially higher future performance and investor re-rating.
1 Jun
Arthur J. Gallagher & Co. pursues acquisitions of specialty insurance businesses to drive sustained expansion and strengthen its market position. Specialty insurance buyouts represent major strategic moves that can significantly shift revenue growth and competitive positioning.